Cantor Fitzgerald Reaffirms Overweight Rating for Tivity Health (NASDAQ:TVTY)

Share on StockTwits

Tivity Health (NASDAQ:TVTY)‘s stock had its “overweight” rating reiterated by stock analysts at Cantor Fitzgerald in a research report issued on Tuesday, The Fly reports. They presently have a $40.00 target price on the stock, down from their prior target price of $45.00. Cantor Fitzgerald’s target price suggests a potential upside of 56.49% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of Tivity Health from a “hold” rating to a “strong sell” rating in a report on Tuesday, December 24th. ValuEngine cut shares of Tivity Health from a “hold” rating to a “sell” rating in a report on Thursday, January 16th. Credit Suisse Group assumed coverage on shares of Tivity Health in a report on Friday, January 3rd. They issued a “neutral” rating and a $22.00 price objective for the company. Barrington Research reiterated a “buy” rating and issued a $38.00 price objective on shares of Tivity Health in a report on Monday, December 23rd. Finally, BidaskClub upgraded shares of Tivity Health from a “buy” rating to a “strong-buy” rating in a report on Wednesday, November 20th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $29.70.

Shares of NASDAQ:TVTY opened at $25.56 on Tuesday. The stock has a market capitalization of $1.23 billion, a PE ratio of 17.87, a P/E/G ratio of 1.12 and a beta of 1.16. Tivity Health has a 1 year low of $14.84 and a 1 year high of $26.07. The firm has a fifty day moving average price of $21.37 and a 200 day moving average price of $18.51. The company has a current ratio of 0.94, a quick ratio of 0.78 and a debt-to-equity ratio of 1.96.

Tivity Health (NASDAQ:TVTY) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.56 by ($0.10). The business had revenue of $303.90 million during the quarter, compared to the consensus estimate of $301.52 million. Tivity Health had a return on equity of 21.67% and a net margin of 6.41%. The company’s revenue for the quarter was up 100.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.59 earnings per share. On average, sell-side analysts forecast that Tivity Health will post 2.17 earnings per share for the current fiscal year.

A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its holdings in Tivity Health by 4.8% during the second quarter. BlackRock Inc. now owns 7,343,863 shares of the company’s stock valued at $120,732,000 after acquiring an additional 337,571 shares during the period. HG Vora Capital Management LLC boosted its holdings in Tivity Health by 850.0% during the second quarter. HG Vora Capital Management LLC now owns 4,750,000 shares of the company’s stock valued at $78,090,000 after acquiring an additional 4,250,000 shares during the period. Morgan Stanley boosted its holdings in Tivity Health by 300.4% during the second quarter. Morgan Stanley now owns 2,771,427 shares of the company’s stock valued at $45,562,000 after acquiring an additional 2,079,309 shares during the period. Bank of America Corp DE boosted its holdings in Tivity Health by 300.0% during the second quarter. Bank of America Corp DE now owns 1,653,998 shares of the company’s stock valued at $27,193,000 after acquiring an additional 1,240,536 shares during the period. Finally, Parametric Portfolio Associates LLC boosted its holdings in Tivity Health by 91.2% during the third quarter. Parametric Portfolio Associates LLC now owns 783,794 shares of the company’s stock valued at $13,035,000 after acquiring an additional 373,782 shares during the period.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Read More: What are economic reports?

The Fly

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Hasbro, Inc.  Expected to Earn Q1 2020 Earnings of $0.01 Per Share
Hasbro, Inc. Expected to Earn Q1 2020 Earnings of $0.01 Per Share
Halozyme Therapeutics, Inc.  to Post Q1 2020 Earnings of  Per Share, Piper Sandler Forecasts
Halozyme Therapeutics, Inc. to Post Q1 2020 Earnings of Per Share, Piper Sandler Forecasts
Q1 2020 EPS Estimates for Helios Technologies  Boosted by William Blair
Q1 2020 EPS Estimates for Helios Technologies Boosted by William Blair
Aergo Price Down 15.4% This Week
Aergo Price Down 15.4% This Week
Skychain  Market Capitalization Achieves $662,118.00
Skychain Market Capitalization Achieves $662,118.00
EveriToken  Trading Down 27.4% Over Last Week
EveriToken Trading Down 27.4% Over Last Week


 
© 2006-2020 Zolmax.